Trial of nedocromil sodium in atopic eczema
- 31 May 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 122 (6) , 817-820
- https://doi.org/10.1111/j.1365-2133.1990.tb06271.x
Abstract
The efficacy of orally administered nedocromil sodium, a mast-cell stabilizer, was assessed in the treatment of adults with atopic eczema plus food allergy. Twenty adults with atopic eczema and allergy to hens'' eggs, cows'' milk or wheat took part in this double-blind, cross-over study of nedocromil sodium versus placebo, each treatment period lasting 4 weeks. No significant differences were found between the two treatments on clinical assessment, or by measurement of total and specific IgE levels.This publication has 8 references indexed in Scilit:
- IgE‐mediated allergy in adults with severe atopic eczemaClinical and Experimental Allergy, 1989
- Increased Intestinal Permeability in Atopic EczemaJournal of Investigative Dermatology, 1986
- Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthmaRespiratory Medicine, 1985
- Nedocromil sodium: a new drug for the management of bronchial asthma.Thorax, 1984
- Precipitins to dietary proteins in atopic eczemaBritish Journal of Dermatology, 1983
- A controlled trial of oral sodium cromoglycate in atopic eczemaBritish Journal of Dermatology, 1982
- INTESTINAL PERMEABILITY IN PATIENTS WITH ECZEMA AND FOOD ALLERGYThe Lancet, 1981
- Precipitins to Dietary Proteins in Serum and Upper Intestinal Secretions of Coeliac ChildrenBMJ, 1972